Small Business Innovation Research · Small Business Technology Transfer
Mattek Corporation: SBIR & STTR awards
66 awards worth $23.45M to 1 companies since 1990 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Mattek Corporation's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2020 | 2 | 0 | $477.1K |
| 2019 | 2 | 0 | $448.9K |
| 2017 | 0 | 1 | $1.20M |
| 2016 | 0 | 1 | $1.33M |
| 2014 | 1 | 0 | $218.3K |
| 2012 | 0 | 1 | $966.5K |
| 2011 | 0 | 3 | $2.75M |
| 2010 | 1 | 0 | $267.9K |
| 2009 | 1 | 3 | $3.12M |
| 2008 | 3 | 0 | $733.6K |
| 2007 | 3 | 1 | $1.11M |
| 2006 | 2 | 0 | $418.7K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
By agency
- Department of Health and Human Services 61 awards · $21.80M
- Department of Defense 5 awards · $1.65M
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Organotypic Culture Models (OCM) developed from experimental animals for Chemical Toxicity Screening. · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $252.1K | 2020-08-21 |
| ELECTROSPUN BIODEGRADABLE MEMBRANE INSERTS (POP:7/27/2020 TO 04/26/2021) · topic 19 | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2020 |
| Organotypic Rat Tissue Models for Translational Toxicity Assessments · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $223.9K | 2019-09-19 |
| Novel Approach for Characterizing Exposure and Response to Engineered Nanomaterials in the Gut · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2019-04-17 |
| Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.20M | 2017-03-01 |
| An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies · topic 300 | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.33M | 2016-02-01 |
| An In Vitro Human Small Intestine Tissue Model for Drug Permeation Studies · topic NIGMS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $218.3K | 2014 |
| Genetically modified tissue engineered in vitro human models · topic NIGMS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $966.5K | 2012 |
| Validation of Human Vaginal Tissue Assay for Endocrine Disruptors · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $993.5K | 2011 |
| Human Corneal Model for Ocular Irritation Assay · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $924.5K | 2011 |
| Validation of an In Vitro Human Airway Model · topic NIEHS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $836.0K | 2011 |
| In Vitro Human Tissue Model for Intravaginal Drug Delivery · topic NIGMS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $267.9K | 2010 |
| Validation of a Human In Vitro Vaginal Irritation Test | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.21M | 2009 |
| In Vitro Tissue Model of Psoriasis | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $871.2K | 2009 |
| Reconstructed Skin Micronucleus Genotoxicity Assay | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $819.1K | 2009 |
| Genetically modifed tissue engineered in vitro human models | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $221.2K | 2009 |
| Globally Harmonized In Vitro Skin Irritation Assay | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $256.0K | 2008 |
| In Vitro Assay to Determine Skin Corrosivity Packing Groups | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $244.4K | 2008 |
| Human Corneal Model for Ocular Irritation Assay | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $233.3K | 2008 |
| In Vitro Assay for Chemical Allergens | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $475.0K | 2007 |
| Tissue Engineered In Vitro Human Airway Models of Asthma and COPD | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $215.5K | 2007 |
| Validation of a Human In Vitro Vaginal Irritation Test | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $212.3K | 2007 |
| Validation of Organotypic Vaginal Tissue Based Assay for Endocrine Disruptors | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $211.8K | 2007 |
| In Vitro Tissue Model of Psoriasis | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $211.0K | 2006 |
| Pre-validation of Tissue Specific Micronucleus Assay for Genotoxicity Testing | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $207.7K | 2006 |
| Validation of an In Vitro Human Airway Model | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $199.9K | 2005 |
| In Vitro Model of the Human Alveolar Epithelium | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $249.4K | 2004 |
| In Vitro Assay For Chemical Allergens | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $206.5K | 2004 |
| Reconstructed Human Oral Tissues | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $874.7K | 2003 |
| In Vitro Culture Model of the Human Blood-Brain Barrier | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $369.1K | 2003 |
| Reconstructed Human Oral Tissues | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $0 | 2003 |
| HUMAN TISSUE MODEL FOR HETEROSEXUAL HIV TRANSMISSION | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.07M | 2002 |
| RECONSTRUCTION OF SKIN MODEL CONTAINING LANGERHANS CELLS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $830.9K | 2002 |
| IN VITRO SKIN MODEL FOR PERCUTANEOUS ABSORPTION STUDIES | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $181.4K | 2002 |
| HIGHLY DIFFERENTIATED TISSUE CULTURE MODELS OF MELANOMA | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $152.2K | 2002 |
| RECONSTRUCTION OF SKIN MODEL CONTAINING LANGERHANS CELLS | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $0 | 2002 |
| HUMAN TISSUE MODEL FOR HETEROSEXUAL HIV TRANSMISSION | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $0 | 2002 |
| Development of a Vaccine for the Treatment and/or Prevention of Cancer | Mattek Corporation · Massachusetts | Department of Defense · Army | SBIR Phase II | $780.0K | 2001 |
| Eyesafe, Multi-function Coherent Doppler Lidar for Stand-Off Bioaerosol Discrimination | Mattek Corporation · Massachusetts | Department of Defense · Office for Chemical and Biological Defense | SBIR Phase II | $730.0K | 2001 |
| Immortized Human Langerhans Cells | Mattek Corporation · Massachusetts | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $427.6K | 2001 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.